We are pleased to introduce you to Wei Song, M.D., Ph.D. Dr. Song is the new Director of the Molecular Pathology Division, Director of the Clinical Genomics Laboratory, and an Assistant Professor of Pathology and Laboratory Medicine at Weill Cornell Medicine. He is also Assistant Attending Pathologist at NewYork-Presbyterian.
We hope you enjoy learning more about him and his research interests, and how the Covid-19 pandemic has affected him.
Wei Song, BM, PhD
Assistant Professor of Pathology and Laboratory Medicine
Question: Congratulations on your promotion to Director of the Molecular Pathology Division. Can you tell us what your broad goals are?
“Thanks. I would like to contribute to revolutionizing the conventional pathology diagnosis in a brand-new era, i.e. applying molecular profiling as a novel diagnostic tool for patient care in the new era of precision diagnosis.”
How will the new position affect your work within the other departments? You'll have a lot on your plate!
“It will be challenging. Fortunately, we already have a strong team and faculty leadership within the Clinical Genomics Laboratory. The already existing framework and departmental support, will allow me to focus on the supervision of quality management and new assay development which are two areas critical for future growth.”
Where do you see the Molecular Division five years from now?
“I’d like to help lead our division to become recognized as a top five comprehensive molecular pathology program covering multiple medical areas including oncology, infectious disease, genetics. We also would like to expand our service to other regional hospitals in New York City.”
How would you describe Molecular Pathology to a person who may have no idea what this department does?
“We are able to make a diagnosis by using each patient’s specific genetic molecular coding, such as DNA or RNA. Such precise diagnosis enables treatment in a much more targeted, accurate and efficient way.”